Antibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms

JAMA: The Journal of the American Medical Association

Volumn 274, Issue 21, 1995, Pages 1706-1713

  Wilson, Walter R ^a   Karchmer, Adolf W ^a   Dajani, Adnan S ^a   Taubert, Kathryn A ^a   Bayer, Arnold ^a   Kaye, Donald ^a   Bisno, Alan L ^a   Ferrieri, Patricia ^a   Shulman, Stanford T ^a   Durack, David T ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; GENTAMICIN; NAFCILLIN; OXACILLIN; PENICILLIN G SODIUM; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; ENTEROCOCCUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS BOVIS;

EID: 0028882425     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03530210060032     Document Type: Article

References (43)

1. Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA. 1989;261:1471-1477.
2. Wilson WR, Zak O, Sande MA. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. J Infect Dis. 1985;151:1028-1033.
3. Karchmer AW, Moellering RC Jr, Maki DG, et al. Single-antibiotic therapy for streptococcal endocarditis. JAMA. 1979;241:1801-1806.
4. Francioli P, Etienne J, Hoigne R, et al. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA. 1992;267:264-267.
5. Stamboulian D, Bonvehi P, Arevalo C, et al. Antibiotic management for outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis. 1991;13(suppl 2):160-163.
6. Fantin B, Carbon C. In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother. 1992;36:907-912.
7. Wilson WR, Thompson RL, Wilkowske CJ, et al. Short-term therapy for streptococcal infective endocarditis: combined intramuscular administration of penicillin and streptomycin. JAMA. 1981;245: 360-363.
8. Francioli P, Ruch W, Stamboulian D, and the International Infective Endocarditis Study Group. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days. Clin Infect Dis. In press.
9. Roberts RB. Streptococcal endocarditis: the viridans and beta hemolytic streptococci. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:191-208.
10. Karchmer AW, Gibbons GW. Infections of prosthetic heart valves and vascular grafts. In: Bisno AL, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices. 2nd ed. Washington, DC: American Society for Microbiology; 1994:213-249.
11. Henry NK, Wilson WR, Roberts RB, et al. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Antimicrob Agents Chemother. 1986; 30:465-467.
12. Roberts SA, Lang SDR, Ellis-Pegler RB. Short-course treatment of penicillin-susceptible viridans streptococcal infective endocarditis with penicillin and gentamicin. Infect Dis Clin Pract. 1993;2:191-194.
13. Enzler MJ, Rouse MS, Henry NK, Geraci JE, Wilson WR. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis. 1987;155:954-958.
14. Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms and clinical management. Infect Dis Clin North Am. 1995;9:497-530.
15. Klein RS, Catalano MT, Edberg SC, Casey JI, Steibigel NH. Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med. 1979;91: 560-562
16. Eliopoulos GM. Enterococcal endocarditis. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:209-223.
17. Eliopoulos GM. Aminoglycoside resistant enterococcal endocarditis. Med Clin North Am. 1993; 17:117-172.
18. Murray BE, Mederski-Samoraj B. Transferable beta-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest. 1983;72:1168-1171.
19. Leclerq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin. N Engl J Med. 1988;319:157-161.
20. Wilson WR, Wilkowske CJ, Wright AJ, et al. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984;100:816-823.
21. Rice LB, Calderwood SB, Eliopoulos GM, Farber BF, Karchmer AW. Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Rev Infect Dis. 1991;13:1-7.
22. Caputo GM, Archer GL, Calderwood SB, et al. Native valve endocarditis due to coagulase-negative staphylococci: clinical and microbiologic features. Am J Med. 1987;83:619-634.
23. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983;98:447-455.
24. Chambers HF. Short-course combination and oral therapies of Staphylococcus aureus endocarditis. Med Clin North Am. 1993;7:69-80.
25. Torres-Tortosa M, de Cueto M, Vergara A, et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Eur J Clin Microbiol Infect Dis. 1994;13:559-564.
26. Korzeniowski O, Sande MA, The National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496-503.
27. Chambers HF, Miller T, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109:619-624.
28. DiNubile MJ. Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come? Eur J Clin Microbiol Infect Dis. 1994;13:533-534.
29. Dworkin RJ, Lee BL, Sande MA, et al. Ciprofloxacin with rifampin: a predominately oral regimen for right sided S aureus endocarditis in intravenous drug abusers. Lancet. 1989;2:1071.
30. Hendershot EF. Fluroquinolones. Infect Dis Clin North Am. 1995;9:715-730.
31. Karchmer AW. Staphylococcus aureus and vancomycin: the sequel. Ann Intern Med. 1991;115: 739-741.
32. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-322.
33. Gilbert DN, Wood CA, Kimbrough RC, the Infectious Diseases Consortium of Oregon. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Antimicrob Agents Chemother. 1991;35:79-87.
34. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674-680.
35. Whitener C, Caputo GM, Weitekamp MR, et al. Endocarditis due to coagulase-negative staphylococci: microbiologic, epidemiologic and clinical considerations. Med Clin North Am. 1993;7:81-96.
36. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg. 1986;92:776-783.
37. Chuard C, Herrmenn M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother. 1991; 35:2611-2616.
38. Geraci JE, Wilson WR. Symposium on infective endocarditis, III: endocarditis due to gram-negative bacteria, report of 56 cases. Mayo Clin Proc. 1982;57:145-148.
39. Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am. 1993;17:313-322.
40. Nahass RG, Weinstein MP, Bartels J, Gocke BJ. Infectious endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive. J Infect Dis. 1990; 162:967-970.
41. Baldassarre JS, Kaye D. Principles and overview of antibiotic therapy. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:169-190.
42. Douglas JL, Dismukes WE. Surgical therapy of infective endocarditis on natural valves. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:397-411.
43. Murphy JG, Foster-Smith K. Management of complications of infective endocarditis with emphasis on echocardiographic findings. Infect Dis Clin North Am. 1993;7:153-165.